Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)


Clinical Trial Description

Kaposi's disease is a multifocal disease with cutaneous expression in more than 95% of cases.

There are 4 forms : Mediterranean, Endemic (Sub-Saharan Africa), iatrogenic and epidemic (HIV) The physiological hypotheses to explain the disease are not clear. A proliferation of immunity cells in blood vessels and also an undetermined role of the human herpes virus 8 (HHV-8) could be involved.

The treatment is complex and not standardized. There are a lot of different treatments.

The purpose of this study is to evaluate the prevalence and described the characteristics and the treatment of the Kaposi's disease in the France's southeast on 10 years, from 2007 to 2017. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03662828
Study type Observational
Source Direction Centrale du Service de Santé des Armées
Contact
Status Enrolling by invitation
Phase
Start date August 1, 2018
Completion date August 2020